The finding could be critical for possible stem cell treatments for the myelinating disease multiple sclerosis. “The problem [with stem cell treatments] is not getting the stem cells; the problem is getting the cells to differentiate at the right stage,” says Fields. Adenosine looks like a promising stop signal for OPCs. And, as a further enticement, Fields showed that a brief exposure...
The Rockefeller University Press
2003
The Rockefeller University Press
2003
You do not currently have access to this content.